Search alternatives:
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
small increased » soil increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
small increased » soil increased (Expand Search)
-
81
-
82
Table1_Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.DOCX
Published 2022“…<p>Small molecule cardiac troponin activators could potentially enhance cardiac muscle contraction in the treatment of systolic heart failure. …”
-
83
Image1_Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.pdf
Published 2022“…<p>Small molecule cardiac troponin activators could potentially enhance cardiac muscle contraction in the treatment of systolic heart failure. …”
-
84
Image3_Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.pdf
Published 2022“…<p>Small molecule cardiac troponin activators could potentially enhance cardiac muscle contraction in the treatment of systolic heart failure. …”
-
85
Image2_Small Molecule RPI-194 Stabilizes Activated Troponin to Increase the Calcium Sensitivity of Striated Muscle Contraction.pdf
Published 2022“…<p>Small molecule cardiac troponin activators could potentially enhance cardiac muscle contraction in the treatment of systolic heart failure. …”
-
86
Significant condition.
Published 2024“…Over time, the content of C-A-H stabilized at 22%, the amount of CH decreased from 19% to 14%, whereas the amount of AFt increased to 15.9% by Day 28. …”
-
87
Summary of responses on the significance of small ruminants as indicated by farmer percentages.
Published 2023Subjects: -
88
-
89
Table_3_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.docx
Published 2022“…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
-
90
Image_5_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif
Published 2022“…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
-
91
Image_4_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif
Published 2022“…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
-
92
Image_2_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif
Published 2022“…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
-
93
Table_2_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.docx
Published 2022“…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
-
94
Image_1_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif
Published 2022“…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
-
95
Image_3_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.tif
Published 2022“…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
-
96
Table_1_Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.docx
Published 2022“…Background<p>Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear.…”
-
97
-
98
Revealing Deformation Mechanisms in Polymer-Grafted Thermoplastic Elastomers via <i>In Situ</i> Small-Angle X‑ray Scattering
Published 2023“…The neat SBS (φ<sub>SBS</sub> = 100%) sample deforms congruently with the macroscopic dimensions, with the domain spacing between spheres increasing and decreasing along and transverse to the stretch direction, respectively. …”
-
99
Revealing Deformation Mechanisms in Polymer-Grafted Thermoplastic Elastomers via <i>In Situ</i> Small-Angle X‑ray Scattering
Published 2023“…The neat SBS (φ<sub>SBS</sub> = 100%) sample deforms congruently with the macroscopic dimensions, with the domain spacing between spheres increasing and decreasing along and transverse to the stretch direction, respectively. …”
-
100